In Vitro Profiling and Mass Balance of the Anti-Cancer Agent Laromustine [14C]-VNP40101M by Rat, Dog, Monkey and Human Liver Microsomes

A-E. F. Nassar, J. Du, M. Belcourt, X. Lin, I. King
{"title":"In Vitro Profiling and Mass Balance of the Anti-Cancer Agent Laromustine [14C]-VNP40101M by Rat, Dog, Monkey and Human Liver Microsomes","authors":"A-E. F. Nassar, J. Du, M. Belcourt, X. Lin, I. King","doi":"10.2174/1874073101004010001","DOIUrl":null,"url":null,"abstract":"Laromustine (VNP40101M; 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino) carbonylhydrazine) is a novel sulfonylhydrazine alkylating agent. For the first time In vitro profiling and mass balance of ( 14 C)-VNP40101M in rat, dog, monkey and human liver microsomes was investigated. Also, the role of human cytochrome P450 (CYP) and flavin-containing monooxygenase (FMO) enzymes in the conversion of ( 14 C)-VNP40101M by NADPH-fortified human liver microsomes was determined. In this study, ( 14 C)-VNP40101M was converted to five radioactive components (C-1, C-2, C-3, C-4 and C-7) after 60 min of incubation with dog, monkey and human liver microsomes. With the exception of C-3, the same components were detected with rat liver microsomes. In the presence of NADPH, after 60 min of incuba- tion, the loss of substrate for rat, dog, monkey and human was 63, 82, 76 and 64%, respectively and mass balance ranged from 91.0 - 99.3%. In the absence of NADPH, after 60 min of incubation with ( 14 C)-VNP40101M (100 �M), the loss of substrate for rat, dog, monkey and human liver microsomes was 59, 53, 61 and 59%, respectively and mass balance ranged from 100.6 - 116.4%. The profiles of metabolites were similar. The relative abundance of individual metabolites was not species dependent. The formation of C-7 was not observed in zero-cofactor (no NADPH) or zero-protein samples, suggesting that its formation was enzymatic. The formation of C-1, C-2, C-3, and C-4 increased with respect to incubation time. Using a panel of CYP enzymes including rCYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6 and 3A4, it was shown that C- 7 formation was catalyzed by CYP2B6 and CYP3A4/5. The results of this study suggest that (1) P450 plays a role in C-7 formation but plays little or no role in the conversion of ( 14 C)-VNP40101M to C-1 through C-4, and (2) the relative abun- dance of individual degradation/metabolite products were not species dependent. These findings provide a comprehensive understanding of the metabolism of this new agent.","PeriodicalId":89636,"journal":{"name":"The open drug metabolism journal","volume":"4 1","pages":"1-9"},"PeriodicalIF":0.0000,"publicationDate":"2010-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The open drug metabolism journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874073101004010001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Laromustine (VNP40101M; 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino) carbonylhydrazine) is a novel sulfonylhydrazine alkylating agent. For the first time In vitro profiling and mass balance of ( 14 C)-VNP40101M in rat, dog, monkey and human liver microsomes was investigated. Also, the role of human cytochrome P450 (CYP) and flavin-containing monooxygenase (FMO) enzymes in the conversion of ( 14 C)-VNP40101M by NADPH-fortified human liver microsomes was determined. In this study, ( 14 C)-VNP40101M was converted to five radioactive components (C-1, C-2, C-3, C-4 and C-7) after 60 min of incubation with dog, monkey and human liver microsomes. With the exception of C-3, the same components were detected with rat liver microsomes. In the presence of NADPH, after 60 min of incuba- tion, the loss of substrate for rat, dog, monkey and human was 63, 82, 76 and 64%, respectively and mass balance ranged from 91.0 - 99.3%. In the absence of NADPH, after 60 min of incubation with ( 14 C)-VNP40101M (100 �M), the loss of substrate for rat, dog, monkey and human liver microsomes was 59, 53, 61 and 59%, respectively and mass balance ranged from 100.6 - 116.4%. The profiles of metabolites were similar. The relative abundance of individual metabolites was not species dependent. The formation of C-7 was not observed in zero-cofactor (no NADPH) or zero-protein samples, suggesting that its formation was enzymatic. The formation of C-1, C-2, C-3, and C-4 increased with respect to incubation time. Using a panel of CYP enzymes including rCYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6 and 3A4, it was shown that C- 7 formation was catalyzed by CYP2B6 and CYP3A4/5. The results of this study suggest that (1) P450 plays a role in C-7 formation but plays little or no role in the conversion of ( 14 C)-VNP40101M to C-1 through C-4, and (2) the relative abun- dance of individual degradation/metabolite products were not species dependent. These findings provide a comprehensive understanding of the metabolism of this new agent.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抗癌药物拉莫司汀[14C]-VNP40101M在大鼠、狗、猴和人肝微粒体的体外分析和质量平衡
Laromustine (VNP40101M;1,2-二(甲基磺酰基)-1-(2-氯乙基)-2-(甲氨基)羰基肼)是一种新型磺酰肼烷基化剂。首次研究了(14c)-VNP40101M在大鼠、狗、猴和人肝微粒体中的体外分析和质量平衡。同时,测定了人细胞色素P450 (CYP)和含黄素单加氧酶(FMO)酶在nadph强化人肝微粒体转化(14c)-VNP40101M中的作用。在本研究中,(14c)-VNP40101M与狗、猴和人肝微粒体孵育60 min后,转化为5种放射性成分(C-1、C-2、C-3、C-4和C-7)。除C-3外,在大鼠肝微粒体中检测到相同的成分。在NADPH存在的情况下,接种60 min后,大鼠、狗、猴和人的底物损失率分别为63%、82%、76%和64%,质量平衡范围为91.0 ~ 99.3%。在没有NADPH的情况下,用(14 C)- vnp40101m (100 μ M)孵育60 min后,大鼠、狗、猴和人肝微粒体的底物损失分别为59%、53%、61%和59%,质量平衡范围为100.6 - 116.4%。代谢物谱相似。个体代谢物的相对丰度不依赖于物种。在无辅酶因子(无NADPH)或无蛋白的样品中未观察到C-7的形成,表明其形成是酶促的。C-1、C-2、C-3和C-4的形成随孵育时间的延长而增加。利用一组cyp1a2、2A6、2B6、2C8、2C9、2C19、2D6和3A4等CYP酶,发现CYP2B6和CYP3A4/5催化了C- 7的形成。本研究结果表明(1)P450在C-7的形成中起作用,但在(14c)- vnp40101m通过C-4转化为C-1的过程中作用很小或没有作用;(2)个体降解/代谢产物的相对丰度不依赖于物种。这些发现提供了对这种新药物代谢的全面了解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Anti-Ischemia Drugs have no Effect on the In Vivo Metabolism of ATP by RBC in Normotensive Restrained Rats# In Vitro Profiling and Mass Balance of the Anti-Cancer Agent Laromustine [14C]-VNP40101M by Rat, Dog, Monkey and Human Liver Microsomes Pharmacokinetics and Hemodynamic Effects of Diltiazem in Rats Following Single vs Multiple Doses In Vivo Pharmacokinetics and Pharmacodynamics of Hyaluronan Infused into Healthy Human Volunteers Examination of the Utility of the High Throughput In Vitro Metabolic Stability Assay to Estimate In Vivo Clearance in the Mouse
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1